Overview
Registration
View Archive

Accreditation/
Credit Designation

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Agios Pharmaceuticals, Astex Pharmaceuticals, Inc; Bristol Myers Squibb and Takeda Oncology.

New Horizons in the Management of Myelodysplastic Syndromes: Exploring Advancements from Low- to High-Risk Disease

New Horizons in the Management of Myelodysplastic Syndromes: Exploring Advancements from Low- to High-Risk Disease


Live, Interactive Webcast
August 25, 2020

6:00 PM – 7:30 PM ET

 



New Horizons in the Management of Myelodysplastic Syndromes: Exploring Advancements from Low- to High-Risk Disease Overview

Myelodysplastic syndromes (MDS) comprise a heterogeneous group of disorders of the blood-forming stem cells in the bone marrow and results in lower than normal numbers of one or more types of blood cells. A rapidly evolving treatment landscape and changes to prognostic scoring systems have created a practice gap for healthcare providers treating patients with MDS.

Benefits of Attending

  • Learn about changes to classification of MDS subtypes and risk stratification
  • Hear expert perspectives on new and emerging treatment options for the management of MDS
  • Integrate recent clinical trial findings into clinical practice

Acknowledgement of Commercial Support

This activity is supported by educational grants from Agios Pharmaceuticals, Astex Pharmaceuticals, Inc; Bristol Myers Squibb and Takeda Oncology.

Learning Objectives

  • Review available tools for MDS classification and risk stratification, based on morphological, clinical, and cytogenetic criteria
  • Outline strategies to individualize therapy in MDS based on risk stratification and patient comorbidities
  • Apply recent clinical trial findings to real-world practice for the management of MDS
  • Summarize data from recent clinical trials evaluating efficacy and safety of novel therapies to treat MDS from low- to high-risk disease

Target Audience

This educational activity is directed toward hematologists, medical oncologists, nurse practitioners, nurses, and fellows who treat patients with myelodysplastic syndromes. Physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of MDS will be invited to participate.

Program Chair

 
Guillermo Garcia-Manero, MDl
Guillermo Garcia-Manero, MD
Professor
Chief, Section of Myelodysplastic Syndromes
Deputy Chair, Translational Research
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Faculty

 
Amy E. DeZern, MD, MHS
Amy E. DeZern, MD, MHS
Associate Professor of Oncology and Medicine
Division of Hematologic Malignancies
Baltimore, MD
 
David P. Steensma, MD
David P. Steensma, MD
Edward P. Evans Chair in MDS Research
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
27282930
Filter By